Cancer chemotheraphy using suicide genes

Surgical Oncology Clinics of North America

Volumn 7, Issue 3, 1998, Pages 505-536

  Singhal, S ^a   Kaiser, L R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER THERAPY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; REVIEW; SUICIDE GENE; CLINICAL TRIAL; GENE VECTOR; METHODOLOGY; NEOPLASM;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS;

EID: 0031596383     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30258-8     Document Type: Review

References (154)

1. Area M.J. Mule J.J. Chang A.E. Genetic approaches to adoptive cellular therapy of malignancy Semin Oncol 23 1996 108 117
2. Austin E.A. Huber B.E. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase Mol Pharmacol 43 1993 380 387
3. Barba D. Hardin J. Sadelain M. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors Proc Natl Acad Sci U S A 91 1994 4348 4352
4. Beck C. Cayeux S. Lupton S.D. The thymidine kinase/ganciclovir-mediated “suicide” effect is variable in different tumor cells Hum Gene Ther 6 1995 1525 1530
5. Bi W.L. Parysek L.M. Warnick R. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy Hum Gene Ther 4 1993 725 731
6. Biron K.K. de Miranda P. Burnette T.C. Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells Antimicrob Agents Chemother 35 1991 2116 2120
7. Black M.E. Newcomb T.G. Wilson H.M. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy Proc Natl Acad Sci U S A 93 1996 3525 3529
8. Blaese R.M. Ishii-Morita H. Mullen C. In situ delivery of suicide genes for cancer treatment Eur J Cancer 30A 1994 1190 1193
9. Bonnekoh B. Greenhalgh D.A. Bundman D.S. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo J Invest Dermatol 104 1995 313 317
10. Bonnekoh B. Greenhalgh D.A. Bundman D.S. Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma J Invest Dermatol 106 1996 1163 1168
11. Boviatsis E.J. Park J.S. Sena-Esteves M. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene Cancer Res 54 1994 5745 5751
12. Bridgewater J.A. Springer C.J. Knox R.J. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954 Eur J Cancer 31A 1995 2362 2370
13. Brody S.L. Jaffe H.A. Han S.K. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors Hum Gene Ther 5 1994 437 447
14. Bruyns C. Gerard C. Velu T. Cancer escape from immune surveillance: How can it be overcome by gene transfer? Eur J Cancer 30A 1994 1176 1181
15. Caruso M. Panis Y. Gagandeep S. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci U S A 90 1993 7024 7028
16. Chen C.Y. Chang Y.N. Ryan P. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the “bystander effect” Hum Gene Ther 6 1995 1467 1476
17. Chen S.H. Chen X.H. Wang Y. Combination gene therapy for liver metastasis of colon carcinoma in vivo Proc Natl Acad Sci U S A 92 1995 2577 2581
18. Chen S.H. Shine H.D. Goodman J.C. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo Proc Natl Acad Sci USA 91 1994 3054 3057
19. Chottiner E.G. Shewach D.S. Datta N.S. Cloning and expression of human deoxycytidine kinase cDNA Proc Natl Acad Sci U S A 88 1991 1531 1535
20. Colak A. Goodman J.C. Chen S.H. Adenovirus-mediated gene therapy for experimental spinal cord tumors: Tumoricidal efficacy and functional outcome Brain Res 691 1995 76 82
21. Colombo B.M. Benedetti S. Ottolenghi S. The “bystander effect”: Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice Hum Gene Ther 6 1995 763 772
22. Consalvo M. Mullen C.A. Modesti A. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory J Immunol 154 1995 5302 5312
23. Cool V. Pirotte B. Gerard C. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma Hum Gene Ther 7 1996 627 635
24. Cooper M.J. Noninfectious gene transfer and expression systems for cancer gene therapy Semin Oncol 23 1996 172 187
25. Cournoyer D. Caskey C.T. Gene therapy of the immune system Annu Rev Immunol 11 1993 297 329
26. Crystal R.G. Transfer of genes to humans: Early lessons and obstacles to success Science 270 1995 404 410
27. Culver K.W. Ram Z. Wallbridge S. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors [see comments] Science 256 1992 1550 1552
28. de Miranda P. Burnette T.C. Biron K.K. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus Antimicrob Agents Chemother 35 1991 2121 2124
29. Descamps V. Duffour M.T. Mathieu M.C. Strategies for cancer gene therapy using adenoviral vectors Journal of Molecular Medicine 74 1996 183 189
30. Eastham J.A. Chen S.H. Sehgal I. Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models Hum Gene Ther 7 1996 515 523
31. Ezzeddine Z.D. Martuza R.L. Platika D. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene New Biologist 3 1991 608 614
32. Fick J. Barker F.G.N. Dazin P. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro Proc Natl Acad Sci U S A 92 1995 11071 11075
33. Fox M.E. Lemmon M.J. Mauchline M.L. Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered Clostridia Gene Therapy 3 1996 173 178
34. Freeman S.M. Ramesh R. Marrogi A.J. Immune system in suicide-gene therapy Lancet 349 1997 2 3
35. Freeman S.M. Abboud C.N. Whartenby K.A. The “bystander effect”: Tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 53 1993 5274 5283
36. Freeman S.M. McCune C. Robinson W. The treatment of ovarian cancer with a gene modified cancer vaccine: A phase I study Hum Gene Ther 6 1995 927 939
37. Freeman S.M. Ramesh R. Shastri M. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells Cancer Lett 92 1995 167 174
38. Freeman S.M. Whartenby K.A. Freeman J.L. In situ use of suicide genes for cancer therapy Semin Oncol 23 1996 31 45
39. Gagandeep S. Brew R. Green B. Prodrug-activated gene therapy: Involvement of an immunological component in the “bystander effect” Cancer Gene Therapy 3 1996 83 88
40. Gailot G. Hallet M.M. Gaschet J. Human HLA-specific T-cell clones with stable expression of a suicide gene: A possible tool to drive and control a graft-versus-host-graft-versus-leukemia reaction? Blood 88 1996 1098 1103
41. Haberkorn U. Altmann A. Morr I. Monitoring gene therapy with herpes simplex vims thymidine kinase in hepatoma cells: Uptake of specific substrates J Nucl Med 38 1997 287 294
42. Haberkorn U. Oberdörfer F. Gebert J. Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine J Nucl Med 37 1996 87 94
43. Hall S.J. Mutchnik S.E. Chen S.H. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer Int J Cancer 70 1997 183 187
44. Hamel W. Magnelli L. Chiarugi V.P. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells Cancer Res 56 1996 2697 2702
45. Harris J.D. Gutierrez A A Hurst H.C. Gene therapy for cancer using tumour-specific prodrug activation Gene Therapy 1 1994 170 175
46. Hart I.R. Tissue specific promoters in targeting systemically delivered gene therapy Semin Oncol 23 1996 154 158
47. Hart I.R. Vile R.G. Targeted gene therapy Br Med Bull 51 1995 647 655
48. Hasegawa Y. Emi N. Shimokata K. Retroviral transfer of HSV1-TK gene into human lung cancer cell line J Mol Med 73 1995 107 112
49. Hoganson D.K. Batra R.K. Olsen J.C. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma Cancer Res 56 1996 1315 1323
50. Huber B.E. Richards C.A. Krenitsky T.A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy Proc Natl Acad Sci U S A 88 1991 8039 8043
51. Huber B.E. Austin E.A. Good S.S. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase Cancer Res 53 1993 4619 4626
52. Huber B.E. Richards C.A. Regulated expression of artificial chimeric genes contained in retroviral vectors: Implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications Journal of Drug Targeting 3 1996 349 356
53. Ido A. Nakata K. Kato Y. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter Cancer Res 55 1995 3105 3109
54. Izquierdo M. Cortes M. de Felipe P. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy Gene Therapy 2 1995 66 69
55. Jia W.W. McDermott M. Goldie J. Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1 [see comments] J Natl Cancer Inst 86 1994 1209 1215
56. Joki T. Nakamura M. Ohno T. Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir Hum Gene Ther 6 1995 1507 1513
57. Jolly D. Viral vector systems for gene therapy Cancer Gene Therapy 1 1994 51 64
58. Kanai F. Shiratori Y. Yoshida Y. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene Hepatology 23 1996 1359 1368
59. Kanai F. Lan K.H. Shiratori Y. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene Cancer Res 57 1997 461 465
60. Kaneko S. Hallenbeck P. Kotani T. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression Cancer Res 55 1995 5283 5287
61. Kaneko Y. Tsukamoto A. Gene therapy of hepatoma: Bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir Cancer Lett 96 1995 105 110
62. Katsuragi T. Sakai T. Tonomura K. Implantable enzyme capsules for cancer chemotherapy from bakers’ yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer Appl Biochem Biotechnol 16 1987 61 69
63. Kennedy P.G. Steiner I. The use of herpes simplex virus vectors for gene therapy in neurological diseases Q J Med 86 1993 697 702
64. Koering C.E. Dupressoir T. Plaza S. Induced expression of the conditionally cytotoxic herpes simplex virus thymidine kinase gene by means of a parvoviral regulatory circuit Hum Gene Ther 5 1994 457 463
65. Kramm C.M. Rainov N.G. Sena-Esteves M. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment Hum Gene Ther 7 1996 1989 1994
66. Kucharczuk J.C. Raper S. Elshami A.A. Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates Hum Gene Ther 7 1996 2225 2233
67. Kucharczuk J.C. Randazzo B. Chang M.Y. Use of a “replication-restricted” herpes virus to treat experimental human malignant mesothelioma Cancer Res 57 1997 466 471
68. Kumagai T. Tanio Y. Osaki T. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements Cancer Res 56 1996 354 358
69. Kuriyama S. Nakatani T. Masui K. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma Hepatology 22 1995 1838 1846
70. Kuriyama S. Nakatani T. Masui K. Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene Anticancer Res 16 1996 2623 2628
71. Kwong Y.L. Chen S.H. Kosai K. Adenoviral-mediated suicide gene therapy for hepatic metastases of breast cancer Cancer Gene Therapy 3 1996 339 344
72. Liang X. Hartikka J. Sukhu L. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy Gene Therapy 3 1996 350 356
73. Link CJ Jr Kolb E.M. Muldoon R.R. Preliminary in vitro efficacy and toxicities studies of the herpes simplex thymidine kinase gene system for the treatment of breast cancer Hybridoma 14 1995 143 147
74. Macri P. Gordon J.W. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir Hum Gene Ther 5 1994 175 182
75. Manome Y. Abe M. Hagen M.F. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir Cancer Res 54 1994 5408 5413
76. Maron A. Gustin T. Le Roux A. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: Long-term followup by magnetic resonance imaging Gene Therapy 3 1996 315 322
77. Mesnil M. Piccoli C. Tiraby G. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins Proc Natl Acad Sci U S A 93 1996 1831 1835
78. Michael M. Fetzer I. Folkers G. Site-directed mutagenesis of herpes simplex virus type 1 thymidine kinase opposes the importance of amino acid positions 251, 321 and 348 for selective recognition of substrate analogs Biochem Biophys Res Commun 209 1995 966 973
79. Miller N. Vile R. Targeted vectors for gene therapy FASEB J 9 1995 190 199
80. Mineta T. Rabkin S.D. Martuza R.L. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant Cancer Res 54 1994 3963 3966
81. Mineta T. Rabkin S.D. Yazaki T. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Nature Medicine 1 1995 938 943
82. Moolten F.L. Mosaicism induced by gene insertion as a means of improving chemotherapeutic selectivity Crit Rev Immunol 10 1990 203 233
83. Moolten F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy Cancer Res 46 1986 5276 5281
84. Moolten F.L. Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J Natl Cancer Inst 82 1990 297 300
85. Moolten F.L. Vonderhaar B.K. Mroz P.J. Transduction of the herpes thymidine kinase gene into premalignant murine mammary epithelial cells renders subsequent breast cancers responsive to ganciclovir therapy Hum Gene Ther 7 1996 1197 1204
86. Moolten F.L. Wells J.M. Heyman R.A. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene Hum Gene Ther 1 1990 125 134
87. Mroz P.J. Moolten F.L. Retrovirally transduced Escherichia coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication Hum Gene Ther 4 1993 589 595
88. Mullen C.A. Kilstmp M. Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system Proc Natl Acad Sci U S A 89 1992 33 37
89. Mullen C.A. Coale M.M. Lowe R. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor Cancer Res 54 1994 1503 1506
90. Mullen C.A. Petropoulos D. Lowe R.M. Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes Cancer Res 56 1996 1361 1366
91. Munshi N.C. Govindarajan R. Drake R. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir Blood 89 1997 1334 1340
92. Nabel G.J. Nabel E.G. Yang Z.Y. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans Proc Natl Acad Sci U S A 90 1993 11307 11311
93. Nabel G.J. Yang Z.Y. Nabel E.G. Direct gene transfer for treatment of human cancer Ann NY Acad Sci 772 1995 227 231
94. Namba H. Iwadate Y. Tagawa M. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging Hum Gene Ther 7 1996 1847 1852
95. O’Malley BW Jr Chen S.H. Schwartz M.R. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model Cancer Res 55 1995 1080 1085
96. O’Malley B.W. Cope K.A. Chen S.H. Combination gene therapy for oral cancer in a murine model Cancer Res 56 1996 1737 1741
97. Obaru K. Fujii S. Matsushita S. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1 Hum Gene Ther 7 1996 2203 2208
98. Oldfield E.H. Ram Z. Culver K.W. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir Hum Gene Ther 4 1993 39 69
99. Ozaki K. Yoshida T. Ide H. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC Hum Gene Ther 7 1996 1483 1490
100. Pardoll D.M. Cancer vaccines Trends Pharmacol Sci 14 1993 202 208
101. Pavlovic J. Nawrath M. Tu R. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V Gene Therapy 3 1996 635 643
102. Perez-Cruet M.J. Trask T.W. Chen S.H. Adenovirus-mediated gene therapy of experimental gliomas J Neurosci Res 39 1994 506 511
103. Qian C. Bilbao R. Bruna O. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase Hepatology 22 1995 118 123
104. Rainov N.G. Kramm C.M. Aboody-Guterman K. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ ganciclovir paradigm Cancer Gene Therapy 3 1996 99 106
105. Ram Z. Culver K.W. Walbridge S. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats [see comments] Cancer Res 53 1993 83 88
106. Ram Z. Culver K.W. Walbridge S. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors J Neurosurg 79 1993 400 407
107. Ram Z. Walbridge S. Shawker T. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats J Neurosurg 81 1994 256 260
108. Ramel C. Evolutionary aspects of human cancer Pharmacogenetics 2 1992 344 349
109. Ramesh R. Marrogi A.J. Munshi A. In vivo analysis of the “bystander effect”: A cytokine cascade Exp Hematol 24 1996 829 838
110. Randazzo B.P. Kucharczuk J.C. Litzky L.A. Herpes simplex 1716—an ICP 34.5 mutant—is severely replication restricted in human skin xenografts in vivo Virology 223 1996 392 395
111. Richards C.A. Austin E.A. Huber B.E. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy Hum Gene Ther 6 1995 881 893
112. Ring C.J. Harris J.D. Hurst H.C. Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter Gene Therapy 3 1996 1094 1103
113. Rogers R.P. Ge J.Q. Holley-Guthrie E. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: Comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase Hum Gene Ther 7 1996 2235 2245
114. Rogulski K.R. Kim J.H. Kim S.H. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity Hum Gene Ther 8 1997 73 85
115. Rosenberg S.A. Aebersold P. Cornetta K. Gene transfer into humans: Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction [see comments] N Engl J Med 323 1990 570 578
116. Rosenfeld M.E. Wang M. Siegal G.P. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma Journal of Molecular Medicine 74 1996 455 462
117. Ross G. Erickson R. Knorr D. Gene therapy in the United States: A five-year status report Hum Gene Ther 7 1996 1781 1790
118. Roth J.A. Cristiano R.J. Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 89 1997 21 39
119. Rowley S. Lindauer M. Gebert J.F. Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer J Surg Oncol 61 1996 42 48
120. Russell S.J. Replicating vectors for gene therapy of cancer: Risks, limitations and prospects Eur J Cancer 30A 1994 1165 1171
121. Salmons B. Gunzburg W.H. Targeting of retroviral vectors for gene therapy Hum Gene Ther 4 1993 129 141
122. Shaughnessy E. Lu D. Chatterjee S. Parvoviral vectors for the gene therapy of cancer Semin Oncol 23 1996 159 171
123. Smith T.A. White B.D. Gardner J.M. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector Gene Therapy 3 1996 496 502
124. Smythe W.R. Hwang H.C. Amin K.M. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system Cancer Res 54 1994 2055 2059
125. Smythe W.R. Hwang H.C. Elshami A A Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy J Thorac Cardiovasc Surg 109 1995 626 630
126. Smythe W.R. Hwang H.C. Elshami A A Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 1995 78 86
127. Smythe W.R. Kaiser L.R. Hwang H.C. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma [see comments] Ann Thorac Surg 57 1994 1395 1401
128. Sterman DH, Treat J, Litzky LA, et al: Adenoviral-mediated herpes simplex virus thymidine kinase gene delivery in patients with localized malignancy: Results of a phase I trial in malignant mesothelioma. Human Gene Therapy, in press
129. Su H. Chang J.C. Xu S.M. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene Hum Gene Ther 7 1996 463 470
130. Sutton M.A. Berkman S.A. Chen S.H. Adenovirus-mediated suicide gene therapy for experimental bladder cancer Urology 49 1997 173 180
131. Takahashi T. Namiki Y. Ohno T. Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes Hum Gene Ther 8 1997 827 833
132. Takamiya Y. Short M.P. Moolten F.L. An experimental model of retrovirus gene therapy for malignant brain tumors J Neurosurg 79 1993 104 110
133. Takenaga K. Tagawa M. Sakiyama S. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells Anticancer Res 16 1996 681 685
134. Tamiya T. Ono Y. Wei M.X. Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine Cancer Gene Therapy 3 1996 155 162
135. Tamura M. Shimizu K. Masanobu Y. Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells Hum Gene Ther 8 1997 381 391
136. Tanaka T. Kanai F. Okabe S. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro Cancer Res 56 1996 1341 1345
137. Tiberghien P. Use of suicide genes in gene therapy J Leukoc Biol 56 1994 203 209
138. Tong X.W. Block A. Chen S.H. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration Gynecol Oncol 61 1996 175 179
139. Trinh Q.T. Austin E.A. Murray D.M. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/ prodrug systems in a human colorectal carcinoma cell line Cancer Res 55 1995 4808 4812
140. Uckert W. Walther W. Retrovirus-mediated gene transfer in cancer therapy Pharmacol Ther 63 1994 323 347
141. Vile R.G. Hart I.R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA Cancer Res 53 1993 3860 3864
142. Vile R. Russell S.J. Gene transfer technologies for the gene therapy of cancer Gene Therapy 1 1994 88 98
143. Vile R.G. Nelson J.A. Castleden S. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component Cancer Res 54 1994 6228 6234
144. Vincent A.J. Vogels R. Someren G.V. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors Hum Gene Ther 7 1996 197 205
145. Wallace H. Clarke A.R. Harrison D.J. Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis Oncogene 13 1996 55 61
146. Wallace P.M. MacMaster J.F. Smith V.F. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine Cancer Res 54 1994 2719 2723
147. Whitley R.J. Herpes simplex virus Fields B.N. Knipe D.M. Virology 1990 Raven New York 1843 1887
148. Yang L. Hwang R. Pandit L. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir Ann Surg 224 1996 405 414
149. Yazaki T. Manz H.J. Rabkin S.D. Treatment of human malignant meningiomas by G207 a replication-competent multimutated herpes simplex virus 1 Cancer Res 55 1995 4752 4756
150. Yee D. McGuire S.E. Brunner N. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer Hum Gene Ther 7 1996 1251 1257
151. Yoshida K. Kawami H. Yamaguchi Y. Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene Cancer 75 1995 1467 1471 6 suppl
152. Zerrouqi A. Rixe O. Ghoumari A.M. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: Improvement of cell sensitization to ganciclovir Cancer Gene Therapy 3 1996 385 392
153. Zhang L. Wikenheiser K.A. Whitsett J.A. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo Hum Gene Ther 8 1997 563 574
154. Zwiebel J.A. Su N. MacPherson A. The gene therapy of cancer: Transgenic immunotherapy Semin Hematol 30 1993 119 128 4 suppl 4